Robert M. Conway

Sydney, NSW 2006, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23 publications

UC2288 decreases the viability and metastatic activity of human Uveal melanoma cells via activating the AMPK/eIF2/ATF4 ER stress axis.

UC2288 decreases the viability and metastatic activity of human Uveal melanoma cells via activating the AMPK/eIF2/ATF4 ER stress axis.

Journal: European journal of pharmacology

Published: August 03, 2025

Survey of Australian primary eyecare management of choroidal nevus patients.

Survey of Australian primary eyecare management of choroidal nevus patients.

Journal: Optometry and vision science : official publication of the American Academy of Optometry

Published: April 23, 2025

Corrigendum to "The multifunctional human ocular melanocortin system" [Prog. Retin. Eye Res. 95 (2023) 1-23 101187].

Corrigendum to "The multifunctional human ocular melanocortin system" [Prog. Retin. Eye Res. 95 (2023) 1-23 101187].

Journal: Progress in retinal and eye research

Published: April 03, 2025

Microdissection of Distinct Morphological Regions Within Uveal Melanomas Identifies Novel Drug Targets.

Microdissection of Distinct Morphological Regions Within Uveal Melanomas Identifies Novel Drug Targets.

Journal: Cancers

Published: September 12, 2024

Choroidal melanoma in a patient with multiple endocrine neoplasia type 1.

Choroidal melanoma in a patient with multiple endocrine neoplasia type 1.

Journal: Canadian journal of ophthalmology. Journal canadien d'ophtalmologie

Published: May 18, 2024

The Fight Tumour Blindness Registry: Efficient capture of high-quality real-world data in uveal melanoma.

The Fight Tumour Blindness Registry: Efficient capture of high-quality real-world data in uveal melanoma.

Journal: Canadian journal of ophthalmology. Journal canadien d'ophtalmologie

Published: January 29, 2024

Lapatinib dysregulates HER2 signaling and impairs the viability of human uveal melanoma cells.

Lapatinib dysregulates HER2 signaling and impairs the viability of human uveal melanoma cells.

Journal: Journal of Cancer

Published: July 25, 2023

The multifunctional human ocular melanocortin system.

The multifunctional human ocular melanocortin system.

Journal: Progress in retinal and eye research

Published: March 14, 2023

The multi-kinase inhibitor afatinib serves as a novel candidate for the treatment of human uveal melanoma.

The multi-kinase inhibitor afatinib serves as a novel candidate for the treatment of human uveal melanoma.

Journal: Cellular oncology (Dordrecht, Netherlands)

Published: June 14, 2022

Congenital Hypertrophy of the Retinal Pigment Epithelium (CHRPE) as a Screening Marker for Familial Adenomatous Polyposis (FAP): Systematic Literature Review and Screening Recommendations.

Congenital Hypertrophy of the Retinal Pigment Epithelium (CHRPE) as a Screening Marker for Familial Adenomatous Polyposis (FAP): Systematic Literature Review and Screening Recommendations.

Journal: Clinical ophthalmology (Auckland, N.Z.)

Published: December 18, 2021

The application of natural compounds in uveal melanoma drug discovery.

The application of natural compounds in uveal melanoma drug discovery.

Journal: The Journal of pharmacy and pharmacology

Published: November 15, 2021

Analysis of Circulating Tumour Cells in Early-Stage Uveal Melanoma: Evaluation of Tumour Marker Expression to Increase Capture.

Analysis of Circulating Tumour Cells in Early-Stage Uveal Melanoma: Evaluation of Tumour Marker Expression to Increase Capture.

Journal: Cancers

Published: November 07, 2021

Showing 1-12 of 23

Last Updated: 09/26/2026